
Sign up to save your podcasts
Or


A $30 million dollar, phase 3 clinical trial is about to begin at Northwestern, investigating whether exercise can slow Parkinson's disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences is leading the trial and explains what he hopes to accomplish.
By Northwestern University Feinberg School of Medicine4.9
2424 ratings
A $30 million dollar, phase 3 clinical trial is about to begin at Northwestern, investigating whether exercise can slow Parkinson's disease progression. Daniel Corcos, PhD, a professor of Physical Therapy and Human Movement Sciences is leading the trial and explains what he hopes to accomplish.

90,967 Listeners

21,953 Listeners

43,582 Listeners

91 Listeners

6,401 Listeners

112,408 Listeners

4 Listeners

56,513 Listeners

0 Listeners

10,215 Listeners

33 Listeners

3,010 Listeners

8,197 Listeners

29,246 Listeners

1,564 Listeners

4,221 Listeners

7 Listeners

580 Listeners

10,615 Listeners